Tembo Global Profit & Loss Annual

BSE: - | NSE: TEMBO | ISIN: INE869Y01010 | Sector: Biotechnology & Drugs

0.00 - (-)Updated :

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	432.08	249.82	175.93	105.32
Total Revenue	432.08	249.82	175.93	105.32
Costof Revenue Total	378.22	206.54	137.73	74.15
Gross Profit	53.86	43.28	38.20	31.17
Selling/ General/ Admin Expenses Total	8.01	5.70	4.93	2.96
Depreciation/ Amortization	2.72	2.59	2.33	1.39
Other Operating Expenses Total	26.83	24.17	25.06	20.52
Total Operating Expense	415.78	238.99	170.05	99.03
Operating Income	16.30	10.82	5.88	6.29
Interest Inc( Exp) Net- Non- Op Total	-48.28	-33.84	-34.64	-22.03
Other Net	7.43	0.44	1.88	-0.05
Net Income Before Taxes	18.90	7.88	4.30	4.04
Provisionfor Income Taxes	4.69	2.09	1.14	1.17
Net Income After Taxes	14.21	5.79	3.15	2.87
Net Income Before Extra Items	14.21	5.79	3.15	3.05
Net Income	14.21	5.79	3.15	3.05
Income Availableto Com Excl Extra Ord	14.21	5.79	3.15	3.05
Income Availableto Com Incl Extra Ord	14.21	5.79	3.15	3.05
Diluted Net Income	14.21	5.79	3.15	3.05
Diluted Weighted Average Shares	1.38	1.11	1.08	1.08
Diluted EPS Excluding Extra Ord Items	10.26	5.22	2.92	2.83
DPS- Common Stock Primary Issue	1.00	1.50	1.20	0.93
Diluted Normalized EPS	10.26	5.22	2.92	2.83
Total Adjustmentsto Net Income	-	-	0.00	0.00
Minority Interest	-	-	-	0.18